Sartorius Stedim Biotech S.A.

ENXTPA:DIM 주식 보고서

시가총액: €15.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sartorius Stedim Biotech 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Rene Faber

최고 경영자

€790.0k

총 보상

CEO 급여 비율68.4%
CEO 임기1.3yrs
CEO 소유권n/a
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간8yrs

최근 관리 업데이트

Recent updates

Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

May 13
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Apr 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Apr 20
With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Feb 19
Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Dec 22
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Dec 01
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Nov 10
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 23
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

May 25
Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

May 09
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Apr 23
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Feb 07
Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Jan 20
Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Nov 09
Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Oct 20
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Oct 03
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Jul 26
We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Jul 09
Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 21
Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Apr 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

Apr 03
Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Feb 24
We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Dec 04
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Aug 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

May 10
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

CEO 보상 분석

Rene Faber 의 보수는 Sartorius Stedim Biotech 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

€255m

Dec 31 2023€790k€540k

€310m

Sep 30 2023n/an/a

€460m

Jun 30 2023n/an/a

€635m

Mar 31 2023n/an/a

€717m

Dec 31 2022€578k€288k

€876m

Sep 30 2022n/an/a

€681m

Jun 30 2022n/an/a

€625m

Mar 31 2022n/an/a

€559m

Dec 31 2021€901k€396k

€414m

Sep 30 2021n/an/a

€523m

Jun 30 2021n/an/a

€469m

Mar 31 2021n/an/a

€398m

Dec 31 2020€742k€396k

€336m

Sep 30 2020n/an/a

€299m

Jun 30 2020n/an/a

€255m

Mar 31 2020n/an/a

€254m

Dec 31 2019€784k€425k

€235m

보상 대 시장: Rene 의 총 보상 ($USD 848.92K ) French 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 4.76M ).

보상과 수익: Rene 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.

CEO

Rene Faber (49 yo)

1.3yrs

테뉴어

€790,000

보상

Dr. Rene Faber serves as Head of Bioprocess Solutions Division and Member of the Executive Board at Sartorius Aktiengesellschaft since January 01, 2019. He serves as Chief Executive Officer at Sartorius St...

이사회 구성원

이름위치테뉴어보상소유권
Rene Faber
CEO & DIrector5.3yrs€790.00k데이터 없음
Joachim Kreuzburg
Non-Executive & Non-Independent Chairman17yrs€693.15k0.000010%
€ 1.5k
Lothar Kappich
Director6.8yrs€84.00k0%
€ 0
Henri Riey
Director17yrs€56.00k0.000010%
€ 1.5k
Pascale Boissel
Independent Director5.3yrs€93.00k0%
€ 0
Anne-Marie Graffin
Lead Independent Director9.2yrs€91.00k0.000010%
€ 1.5k
Susan Dexter
Independent Director9.2yrs€84.00k0.000010%
€ 1.5k
Romaine Fernandes
Employee Representative Non - Executive Directorless than a year데이터 없음0%
€ 0

8.0yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: DIM 의 이사회는 경험(평균 재직 기간 8 년)으로 간주됩니다.